Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Coronavirus Notebook: EMA Expects First Vaccine Efficacy Data Soon, ACT-Accelerator Needs Urgent Funding

Sep 11 2020

• By Ian Schofield

Covid19_Update — Coronavirus vaccine supply deals are in the spotlight • Source: Shutterstock

Related Content

EU Approves Gilead’s Remdesivir For COVID-19 In Record Time

Jul 03 2020

AstraZeneca CEO: 2020 Approval For COVID Vaccine Still Possible

Sep 10 2020

EU Says First COVID-19 Vaccinations Available By Year-End

Sep 08 2020

COVID-19 Vaccine Sponsors’ Pledge To Wait For Phase III Helps US FDA

Sep 09 2020

Related Companies

Gilead Sciences, Inc.

Pfizer Inc.

BioNTech SE

AstraZeneca PLC

Additional Topics

Europe Denmark United States Coronavirus COVID-19 Vaccines Clinical Trials Regulation Review Pathway BioPharmaceutical Infectious Diseases

More from Europe

More from Geography

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window